Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.

Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares ...

Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with ...

Shares of Merck & Co. Inc. MRK slid 1.81% to $88.05 Thursday, on what proved to be an all-around mixed trading session for ...

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

Democrats are still raising concerns about Kennedy’s potential to profit from anti-vaccine advocacy and lawsuits, but ...

Three major drug companies — Merck, Eli Lilly and Amgen — sued to block the rule, in part on First Amendment grounds. The judge didn’t take a view on that question, though, instead ruling ...

The letter also notes RFK Jr.’s intent to continue collecting fees over lawsuits against the pharmaceutical company Merck. The suits allege that the company failed to properly warn consumers ...